These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17346176)

  • 1. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.
    Cook WJ; DeLucas LJ; Chattopadhyay D
    Protein Sci; 2000 Apr; 9(4):704-12. PubMed ID: 10794412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylamine and Carboxymethoxylamine Can Inhibit
    Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase.
    Radke JB; Melillo B; Mittal P; Sharma M; Sharma A; Fu Y; Uddin T; Gonse A; Comer E; Schreiber SL; Gupta AK; Chatterjee AK; Sibley LD
    Nat Commun; 2022 Jan; 13(1):459. PubMed ID: 35075105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion and egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs.
    Lavine MD; Arrizabalaga G
    Curr Pharm Des; 2007; 13(6):641-51. PubMed ID: 17346179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Rais RH; Al Safarjalani ON; Yadav V; Guarcello V; Kirk M; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2005 May; 69(10):1409-19. PubMed ID: 15857605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting
    Palencia A; Bougdour A; Brenier-Pinchart MP; Touquet B; Bertini RL; Sensi C; Gay G; Vollaire J; Josserand V; Easom E; Freund YR; Pelloux H; Rosenthal PJ; Cusack S; Hakimi MA
    EMBO Mol Med; 2017 Mar; 9(3):385-394. PubMed ID: 28148555
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; El Kouni MH
    Biochem Pharmacol; 2010 Oct; 80(7):955-63. PubMed ID: 20541538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase.
    Darling JA; Sullivan WJ; Carter D; Ullman B; Roos DS
    Mol Biochem Parasitol; 1999 Sep; 103(1):15-23. PubMed ID: 10514077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii.
    Chaudhary K; Darling JA; Fohl LM; Sullivan WJ; Donald RG; Pfefferkorn ER; Ullman B; Roos DS
    J Biol Chem; 2004 Jul; 279(30):31221-7. PubMed ID: 15140885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.
    el Kouni MH; Guarcello V; Al Safarjalani ON; Naguib FN
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2437-43. PubMed ID: 10508021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
    Kortagere S; Mui E; McLeod R; Welsh WJ
    J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.